By Editor , 9 September 2026
Tyra to Reveal SURF302 Bladder Cancer Data Sept. 9

Carlsbad – September 08, 2026 -- Tyra Biosciences, Inc. (Nasdaq: TYRA) will disclose initial clinical results from its SURF302 Phase 2 study of oral dabogratinib in intermediate risk non-muscle invasive bladder cancer (IR NMIBC) during a conference call scheduled for September 9, 2026, at 8:00 am ET.

By Editor , 9 September 2026
TFP Sells Illume Fertility to IVI RMA, Sharpens Canada Focus

Toronto – September 08, 2026 -- The Fertility Partners (TFP), Canada's largest fertility clinic network, has completed the sale of Illume Fertility, a Connecticut- and New York-based fertility practice, to IVI RMA North America, closing the deal on September 3, 2026.

By Editor , 9 September 2026
Markel Partners With Midwest to Expand California Workers Comp

Richmond, Va. – September 08, 2026 -- Markel, the insurance operations within Markel Group Inc. (NYSE: MKL), has entered a strategic collaboration with Midwest General Insurance Agency, LLC, an Acrisure subsidiary, to expand workers compensation insurance offerings in California.

By Editor , 9 September 2026

Melbourne – September 08, 2026 -- Dimerix Limited (ASX: DXB) has secured non-dilutive loan facility agreements worth up to A$34 million with a syndicate of Australian and U.S. lenders, expanding on its previously announced A$10 million SKIPTAN facility.

By Editor , 9 September 2026

Alameda, Calif. – September 08, 2026 -- Acepodia (6976: TT) said the U.S. Food and Drug Administration has cleared its Investigational New Drug application for ACE723, a GPC3-targeted dual-payload antibody-drug conjugate, clearing the way for a Phase 1 clinical trial in unresectable or metastatic hepatocellular carcinoma (HCC).

By Editor , 9 September 2026
HoneyNaps Cuts 24 PSG Wires to Four Wireless Skin Patches

Boston – September 08, 2026 -- HoneyNaps has developed a wireless polysomnography (PSG) system that replaces more than 24 wired sensors with four compact skin patches, combining patch-based sensing with AI-driven sleep analysis.

By Editor , 9 September 2026
Hyperscale Data Sells Bitcoin to Fund Michigan AI Data Center Buildout

Las Vegas – September 08, 2026 -- Hyperscale Data, Inc. (NYSE American: GPUS) held approximately $36 million in cash and restricted cash and roughly 215 Bitcoin as of September 3, 2026, with combined assets totaling near $53 million against a Bitcoin price of approximately $81,500 per coin.